Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00348621 · ClinicalTrials.gov registry record · Phase 4

A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents

A Phase 4 study of Cataract and Low Vision, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 4
Development phase
2,544
Enrollment target
1
Study location

NCT00348621: Completed Phase 4 study of Cataract and Low Vision, sponsored by Johns Hopkins University.

NCT00348621 is a Phase 4 study of Cataract and Low Vision that has completed, run by Johns Hopkins University. The registered enrollment target is 2,544 participants, above the 198-participant average among 83 other Cataract trials with a reported enrollment target (1185% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00348621, a Phase 4 study of Cataract and Low Vision, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 4
Development phase
2,544 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to determine if interventions within the nursing home to restore vision, or cope with visual loss, in residents with visual impairment result in improvement or less decline in mobility scores, and socialization scores, compared to residents with visual impairment in nursing homes with no such intervention. The investigators hypothesized that nursing home residents with visual loss who receive cataract surgery, or refractive correction, or low vision aids would have have better socialization scores and mobility scores at 6 months and 12 months compared to nursing home residents with visual impairment who are advised to seek services, but have no specific program.

Primary Outcome

questionnaire to nurses in charge of nursing home patients on specific items on mobility, which were used to create mobility score

Interventions

  • PROCEDURE Visual impairment intervention program

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 2,544 participants
Start Date 1999-06
Est. Completion 2002-06
Phase Phase 4
Johns Hopkins University

1,448 total trials

What the finished NCT00348621 record still lists

NCT00348621 is an interventional study that assigns participants to a tested intervention. Its 2,544 participants enrollment target places it among the larger protocols in the corpus, above the 198-participant average among 83 other Cataract trials with a reported enrollment target (1185% higher).

The record links to 3 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Visual impairment intervention program is the first listed.

NCT00348621 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00348621 about?

NCT00348621 is a clinical study titled "A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents". The purpose of this clinical trial is to determine if interventions within the nursing home to restore vision, or cope with visual loss, in residents with visual impairment result in improvement or less decline in mobility scores, and socialization scores, compared to residents with visual impairmen...

What is the current status of trial NCT00348621?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,544 participants. The study started on 1999-06. Estimated completion is 2002-06.

What conditions does trial NCT00348621 study?

This clinical trial studies the following conditions: Cataract, Low Vision, Refractive Error.

What interventions are being tested in trial NCT00348621?

The interventions under investigation include: Visual impairment intervention program (PROCEDURE).

Who is sponsoring clinical trial NCT00348621?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00348621 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00348621's enrollment target sits among peer trials

2,544 2nd of 83 the highest of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05931276 · 2,540 participants · Phase 3

    CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

  • NCT00018057 · 2,530 participants · Phase 2

    Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

  • NCT04142177 · 2,529 participants · NA

    Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

  • NCT06018285 · 2,572 participants · NA

    Stepped Approach to Reducing Risk of Suicide in Primary Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00348621, the US trial registry maintained by the National Library of Medicine. NCT00348621 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.